Drug induced liver injury prevention: Difference between revisions
m (Template) |
mNo edit summary |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Drug induced liver injury}} | {{Drug induced liver injury}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{rachita}} | ||
==Overview== | ==Overview== | ||
Given that many cases of drug induced liver injury are idiosyncratic, it is often not possible to prevent injury. | |||
==Primary Prevention== | ==Primary Prevention== | ||
Primary prevention strategies following drug induced liver injury include patient education on drug-drug interactions and safe dosing from known hepatotoxic drugs (e.g. acetaminophen). Currently, [[Drug_induced_liver_injury_screening|screening]] with routine serum alanine aminotransferase monitoring is controversial. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary prevention strategies following drug induced liver injury include prompt withdrawal of the inciting drug, which is also the mainstay of [[Drug induced liver injury medical therapy|treatment]] for this disease. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 19:47, 26 October 2016
|
Drug induced liver injury Microchapters |
|
Differentiating Drug Induced Liver Injury from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Drug Induced Liver Injury On the Web |
|
American Roentgen Ray Society Images of Drug induced liver injury |
|
Risk calculators and risk factors for Drug induced liver injury |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rachita Navara, M.D. [2]
Overview
Given that many cases of drug induced liver injury are idiosyncratic, it is often not possible to prevent injury.
Primary Prevention
Primary prevention strategies following drug induced liver injury include patient education on drug-drug interactions and safe dosing from known hepatotoxic drugs (e.g. acetaminophen). Currently, screening with routine serum alanine aminotransferase monitoring is controversial.
Secondary Prevention
Secondary prevention strategies following drug induced liver injury include prompt withdrawal of the inciting drug, which is also the mainstay of treatment for this disease.